Carl Simpson

Carl Simpson

Mr. Simpson is a seasoned and accomplished entrepreneur, leader, advisor, and investor in the medical and medical device arena and leverages more than 40 years experience in the field. His journey in the medical device world began at Advanced Cardiovascular Systems, where he was a founder and assumed significant clinical and operational leadership as vice president of research and development. ACS was successfully sold to Eli Lilly in 1984. After ACS, he continued to pursue his entrepreneurial passion, working to establish more than 25 medical device companies. In 2004, he worked with Versant Ventures gaining experience in venture capital and helping to define new companies for future investment. Mr. Simpson is a founder and current managing director at Coronis Ventures, and he actively participates as a board member for multiple medical device companies, including Novobionics, Curant Medical, CoRepair, Uptake Medical, TiVaMed/Viveve, and EnTent.

Mr. Simpson received a BA in microbiology/medical technology from San Jose State University, and an MBA and M.S.E.E. in electrical engineering/computer science from the University of Santa Clara.